Research programme: thrombosis therapy - Medicure

Drug Profile

Research programme: thrombosis therapy - Medicure

Alternative Names: MC 45228; MC-45308

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medicure
  • Class Pyridines; Small molecules
  • Mechanism of Action Platelet aggregation inhibitors; Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes - Thrombosis

Highest Development Phases

  • No development reported Thrombosis

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Thrombosis in Canada
  • 25 Jan 2012 Research programme: thrombosis therapy - Medicure is still available for licensing. http://www.medicure.com
  • 02 Dec 2010 Research programme: thrombosis therapy - Medicure is still available for licensing. http://www.medicure.com
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top